EA013616B1 - Инъекционные препараты диклофенака и его фармацевтически приемлемых солей - Google Patents

Инъекционные препараты диклофенака и его фармацевтически приемлемых солей Download PDF

Info

Publication number
EA013616B1
EA013616B1 EA200701645A EA200701645A EA013616B1 EA 013616 B1 EA013616 B1 EA 013616B1 EA 200701645 A EA200701645 A EA 200701645A EA 200701645 A EA200701645 A EA 200701645A EA 013616 B1 EA013616 B1 EA 013616B1
Authority
EA
Eurasian Patent Office
Prior art keywords
diclofenac
composition
injection
approximately
water
Prior art date
Application number
EA200701645A
Other languages
English (en)
Russian (ru)
Other versions
EA200701645A1 (ru
Inventor
Кетан Раджнибхаи Пател
Милан Раджнибхаи Пател
Original Assignee
Троикаа Фармасьютикалз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36953757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA013616(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Троикаа Фармасьютикалз Лтд. filed Critical Троикаа Фармасьютикалз Лтд.
Publication of EA200701645A1 publication Critical patent/EA200701645A1/ru
Publication of EA013616B1 publication Critical patent/EA013616B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EA200701645A 2005-02-01 2006-01-30 Инъекционные препараты диклофенака и его фармацевтически приемлемых солей EA013616B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN96MU2005 2005-02-01
PCT/IN2006/000033 WO2006095363A2 (en) 2005-02-01 2006-01-30 Injectable preparations of diclofenic and its pharmaceutically acceptable salts

Publications (2)

Publication Number Publication Date
EA200701645A1 EA200701645A1 (ru) 2008-02-28
EA013616B1 true EA013616B1 (ru) 2010-06-30

Family

ID=36953757

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701645A EA013616B1 (ru) 2005-02-01 2006-01-30 Инъекционные препараты диклофенака и его фармацевтически приемлемых солей

Country Status (20)

Country Link
US (1) US8809393B2 (enExample)
EP (1) EP1848419B1 (enExample)
JP (1) JP2008528572A (enExample)
KR (1) KR101226121B1 (enExample)
CN (1) CN101123957B (enExample)
AP (1) AP2888A (enExample)
AU (2) AU2006221633B2 (enExample)
BR (1) BRPI0606119B8 (enExample)
CA (1) CA2596031C (enExample)
DK (1) DK1848419T3 (enExample)
EA (1) EA013616B1 (enExample)
ES (1) ES2392097T3 (enExample)
IL (1) IL184697A (enExample)
MX (1) MX2007009312A (enExample)
NZ (1) NZ554779A (enExample)
PL (1) PL1848419T3 (enExample)
PT (1) PT1848419E (enExample)
UA (1) UA93365C2 (enExample)
WO (1) WO2006095363A2 (enExample)
ZA (1) ZA200705729B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009155315A (ja) * 2007-12-26 2009-07-16 Fujiyakuhin Co Ltd 注射剤
WO2013005226A1 (en) * 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103432132B (zh) * 2013-08-31 2015-01-21 西南大学 甲磺酸普立地诺双氯芬酸钠注射液及其制备方法
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0595766A1 (de) * 1992-10-22 1994-05-04 Ciba-Geigy Ag Parenterale Lösungen für Diclofenacsalze
US20030139437A1 (en) * 1999-01-11 2003-07-24 Dobrozsi Douglas Joseph Compositions having improved delivery of actives
CH694034A5 (de) * 2002-12-12 2004-06-30 Mepha Ag Diclofenac-Kalium Injektionslösung.
US20040157928A1 (en) * 2003-02-12 2004-08-12 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200488L (sv) 1982-01-29 1983-07-30 Svenska Flaektfabriken Ab Arreteringsanordning, serskilt for forankring av till- och franluftventiler i ventilationskanaler
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US5554650A (en) * 1994-07-28 1996-09-10 Southern Research Institute Antiphlogistic, analgesic, antipyretic injection preparation
GB9502695D0 (en) 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
WO1997049411A1 (en) * 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US5853263A (en) * 1996-08-15 1998-12-29 Accrued, Inc. System for installing raised road markers
DE10105576C1 (de) * 2001-02-07 2002-08-08 Underberg Kg Flasche mit im Boden ausgebildeten Griffmulden
IN192711B (enExample) 2002-01-22 2004-05-15 Ketan Rajnibhai Patel
KR100612070B1 (ko) * 2003-02-12 2006-08-11 알앤피코리아주식회사 용출률이 향상된 난용성 약제의 용매 시스템 및 이를 함유한 제약학적 제제
CN1557290A (zh) 2004-01-19 2004-12-29 江苏扬子江药业集团有限公司 复方双氯芬酸钾注射液制剂
AU2004317520B2 (en) 2004-03-10 2011-06-09 Shimoda Biotech (Pty) Ltd Stable injectable diclofenac compositions
CN1279897C (zh) 2004-04-30 2006-10-18 济南百诺医药科技开发有限公司 含有双氯芬酸盐和利多卡因的冻干制剂及其制备方法
ITMI20041245A1 (it) 2004-06-22 2004-09-22 Ibsa Inst Biochimique Sa Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0595766A1 (de) * 1992-10-22 1994-05-04 Ciba-Geigy Ag Parenterale Lösungen für Diclofenacsalze
US20030139437A1 (en) * 1999-01-11 2003-07-24 Dobrozsi Douglas Joseph Compositions having improved delivery of actives
CH694034A5 (de) * 2002-12-12 2004-06-30 Mepha Ag Diclofenac-Kalium Injektionslösung.
US20040157928A1 (en) * 2003-02-12 2004-08-12 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate

Also Published As

Publication number Publication date
US20080153914A1 (en) 2008-06-26
BRPI0606119B8 (pt) 2021-05-25
NZ554779A (en) 2011-02-25
KR101226121B1 (ko) 2013-01-25
DK1848419T3 (da) 2012-11-05
PL1848419T3 (pl) 2012-12-31
BRPI0606119A2 (pt) 2009-06-02
CA2596031A1 (en) 2006-09-14
EP1848419B1 (en) 2012-07-25
CN101123957A (zh) 2008-02-13
MX2007009312A (es) 2008-03-10
UA93365C2 (ru) 2011-02-10
AU2009233594A1 (en) 2009-11-19
WO2006095363A2 (en) 2006-09-14
ES2392097T3 (es) 2012-12-04
IL184697A0 (en) 2007-12-03
CA2596031C (en) 2013-02-19
CN101123957B (zh) 2010-12-08
WO2006095363A3 (en) 2006-12-14
EA200701645A1 (ru) 2008-02-28
KR20070107091A (ko) 2007-11-06
AU2006221633B2 (en) 2009-07-30
JP2008528572A (ja) 2008-07-31
IL184697A (en) 2014-02-27
US8809393B2 (en) 2014-08-19
AP2007004101A0 (en) 2007-08-31
PT1848419E (pt) 2012-10-31
EP1848419A2 (en) 2007-10-31
WO2006095363B1 (en) 2007-02-01
BRPI0606119B1 (pt) 2019-05-07
AU2006221633A1 (en) 2006-09-14
ZA200705729B (en) 2008-08-27
AP2888A (en) 2014-05-31

Similar Documents

Publication Publication Date Title
US4056635A (en) 2,6-Diisopropylphenol as an anaesthetic agent
US10946030B2 (en) Formulations of deoxycholic acid and salts thereof
AU2016202661B2 (en) Formulations of deoxycholic acid and salts thereof
Frenken et al. Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection
KR910005885B1 (ko) 염화리소짐 및 글리치르히진산 디칼륨 함유 수용액제제
US20220072011A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
AU2006250765A1 (en) Injectable compositions and process for preparation of such compositions
AU2009233594A1 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
JP3954115B2 (ja) 注射剤および注射剤キット
US9211251B2 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
ES2215856T3 (es) Solucion de sal monosodica tetrahidrato de n-(o-(p-pivaloiloxibenceno-sulfonilamino)benzoil)glicina y medicamento que contiene esta solucion.
KR100514009B1 (ko) 1,2,4-벤조트리아진옥사이드제제
KR20060002795A (ko) 엔도톡신-관련 질병 및 질환의 예방 및 치료용 조성물 및방법
TW202114717A (zh) 含有對硼苯基丙胺酸之注射液劑
WO2026057806A1 (en) Injectable dosage form of 2-[6-(4-cyclopropyl-4h-1,2,4-triazol-3-yl)-2-pyridyl]-5-morpholinocarbonyl-1-isoindolinone
WO1994026110A1 (en) Stable quinolone and naphthyridine premix formulations
KR20250070034A (ko) 오렐라닌 제제
HK40067136A (zh) 含有对二羟硼基苯丙氨酸的注射液剂
MXPA94003569A (en) Stable quinolone and naphthyridine premix formulations
JP2018039815A (ja) デオキシコール酸およびその塩類の製剤

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD